Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

3.97
Delayed Data
As of 3:59pm ET
 +0.08 / +2.06%
Today’s Change
1.83
Today|||52-Week Range
14.50
+104.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues46.4M32.5M36.7M41.5M
 
 
 
 
 
Cost of Goods Sold14.5M11.2M12.2M10.8M
 
 
 
 
 
Depreciation And Amortization28.2M23.7M21.1M20.7M
 
 
 
 
 
 
Operating ExpensesGross Income3.7M-2.4M3.5M9.9M
 
 
 
 
 
General Expenses26.7M26.9M28.0M23.9M
 
 
 
 
 
Research And Development2.6M928.0K2.5M1.7M
 
 
 
 
 
Total Operating Expenses69.4M61.8M61.2M55.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.1M-29.3M-24.5M-14.0M
 
 
 
 
 
Extraordinary Credit141.0K12.3M4.1M0.00
 
 
 
 
Extraordinary Charge-27.8M--0.00-3.0M
 
 
 
Interest Expense On Debt9.3M9.0M8.9M8.9M
 
 
 
 
 
Other Expenses-768.0K138.0K-1.8M-621.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-60.8M-25.9M-31.1M-26.4M
 
 
 
 
 
Income Taxes-20.9M-35.0K-10.0K-1.0K
 
 
 
 
 
Net Income-81.7M-25.9M-31.1M-26.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.1M6.1M6.7M8.8M
 
 
 
 
 
Shares To Calculate EPS Diluted6.1M6.1M6.7M8.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$13.40-$4.20-$4.70-$29.90
 
 
 
 
 
EPS Diluted-$13.40-$4.20-$4.70-$2.99